Public Health

Global Call for Early Arthritis Intervention: Dr Mark Hawass of Arthritis VIP Highlights the Need for Action as Global Epidemic Looms

[PRESSWIRE] US – 04.11.24 — Dr Mark Hawass, the award-winning founder of Arthritis VIP and creator of the revolutionary ‘VIP Biohacking Method’, is calling for urgent global action to address the escalating arthritis epidemic.

Expert panel calls for EU to introduce ‘fast-track’ system for approval of new technologies to treat stroke

[PRESSWIRE] IRELAND – 14 May, 2024 — A group of the world’s leading experts in the treatment of stroke are calling on the EU to make sweeping changes to regulations governing the development of medical devices, adding that the current rules are inhibiting innovation and preventing patients from accessing life-saving care.

At 114, America’s Oldest Person “Just Feels Like Living Every Day”

[PRESSWIRE] Houston, Texas, United States – 29 April, 2024 — Despite knowing her age better than anyone, Elizabeth Francis still reacts with disbelief when someone states it out loud. But a paper trail covering more than a century leaves no doubt: Ms. Francis is 114 years old, making her the oldest known person in the United States.

WORLD’S OLDEST MAN DIES AT 114

Juan Vicente Pérez Mora Was Fourth Oldest Man In World History

Unveiling the Future of User Experience: UX Nordic 2024

[PRESSWIRE] Denmark – 11.03.24 — Designers, researchers, writers, and other UX innovators from across the globe are set to converge in the vibrant city of Aarhus for UX Nordic 2024 – one of Europe’s biggest UX events. Set across three days from 28th-30th August, UX Nordic offers attendees a jam-packed schedule of learning, networking and socialising opportunities, finishing up with a lavish, black-tie awards ceremony.

Coalition for Parents and Children PAC and Donna Washington lead first successful legal challenge of initiative creating amorphous right to “reproductive freedom” in country post-Dobbs

[PRESSWIRE] RENO, Nevada, November 27, 2023 — On Tuesday, November 21, 2023, Judge Russell struck down the proposed constitutional amendment initiative C-01-2023, finding it does not embrace a single subject, contains a misleading description of effect, and contains an unfunded mandate in violation of NRS 295.009 and Article 19, Section 6, of the Nevada Constitution.

VEG POWER LAUNCHES GROUND-BREAKING PUBLIC HEALTH CAMPAIGN TO IMPROVE FAMILIES’ DIETS

[PRESSWIRE] London, UK – 18th October, 2023 — Veg Power, the not-for-profit alliance to increase the UK’s vegetable consumption, launched its second ground-breaking public health campaign ‘Simply Veg’ today.

Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023

PMN310 demonstrated greater selectivity for target toxic oligomers over monomers compared to other amyloid-beta-directed antibodies Greater selectivity of PMN310 for toxic oligomers indicates a potentially differentiated profile and supports further development

ETHIOPIA AND THE NETHERLANDS ENDORSE A GROUNDBREAKING PRIVATE SECTOR WATER MANAGEMENT INITIATIVE TO IMPROVE WATER NEEDS FOR OVER 10 MILLION PEOPLE

“In a joint press statement today, the Government of the Federal Democratic Republic of Ethiopia and the Kingdom of the Netherlands, along with their partners, endorsed an innovative initiative to implement Water Management through a fully digital approach. This groundbreaking endeavor has the potential to significantly improve the water quality, facilitate direct access, and increase the availability of water volumes for approximately 10 million individuals residing the metropolitan area of Addis Ababa”.

Fabricantes de comida más importantes del mundo demasiado dependientes en comida no saludable – Revela nuevo análisis

[PRESSWIRE] Londres – 03.03.23 – Cuatro de los fabricantes de comida más importantes del mundo dependen demasiado en comida no saludable a pesar de que afirman estar trabajando en mejorar los valores de sus productos – Esto se basa en un nuevo análisis publicado hoy por un grupo experto de investigación en estos temas, World Action on Salt, Sugar & Health (WASSH) y apoyado por la ONG de inversión responsable, ShareAction.

Une nouvelle analyse révèle que les plus grands fabricants d’aliments au monde dépendent excessivement des ventes d’aliments malsains

[PRESSWIRE] Londres – Le 03.03.23 — Selon une NOUVELLE analyse publiée aujourd’hui par le groupe de recherche d’experts World Action on Salt, Sugar & Health (WASSH) et soutenue par l’ONG d’investissement responsable ShareAction, quatre des plus grands fabricants d’aliments au monde sont trop dépendants des ventes d’aliments malsains, malgré qu’ils prétendent améliorer les qualités nutritionnelles de leurs aliments.

World’s Biggest Food Manufacturers Over Reliant on Sales of Unhealthy Foods – New Analysis Reveals

[PRESSWIRE] London – 03.03.23 — Four of the world’s biggest food manufacturers are over reliant on the sales of unhealthy food despite each claiming to be active in improving the healthfulness of their products – that’s according to NEW analysis published today by expert research group, World Action on Salt, Sugar & Health (WASSH) and supported by responsible investment NGO, ShareAction.

Detecting Multiple Diseases At Once: EU-Funded Didida Project Develops A Cost-Effective Mobile Based Solution In Africa

[PRESSWIRE] Nairobi – November 9, 2022 — The Digital Innovations and Diagnostics for Infectious Diseases in Africa (Didida) had its official kick-off at the Strathmore University. Didida is an ambitious project to develop reliable, low-cost, mobile phone-connected tests to help detect multiple infectious diseases and non-communicable diseases (NCD) at once in sub-Saharan Africa. Didida also plans to invest in digital health infrastructure and train a new generation of African experts to meet the health needs of the continent.

Detecting Multiple Diseases At Once: EU-Funded Didida Project Develops A Cost-Effective Mobile Based Solution In Africa

[PRESSWIRE] Nairobi – November 9, 2022 — The Digital Innovations and Diagnostics for Infectious Diseases in Africa (Didida) had its official kick-off at the Strathmore University. Didida is an ambitious project to develop reliable, low-cost, mobile phone-connected tests to help detect multiple infectious diseases and non-communicable diseases (NCD) at once in sub-Saharan Africa. Didida also plans to invest in digital health infrastructure and train a new generation of African experts to meet the health needs of the continent.

ProMIS Neurosciences Announces Debt Amendment and Conversion

[PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Massachusetts – June 22, 2022 – ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (“ProMIS” or the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers, implicated in the development of neurodegenerative diseases, is pleased to announce that it has entered into debenture amendments with seven (7) creditors to settle an aggregate of US$7,000,000 of indebtedness via the issuance of 70,000,000 Series 1 Preferred Shares (“Series 1 Shares”) of the Company at US$0.10 per share.

NemaLife and UC Davis enter into a research partnership to test the therapeutic potential of several novel psychoplastogens developed in David E. Olson’s Lab

[PRESSWIRE] LUBBOCK, TX — April 19, 2022 – NemaLife Inc., a DEA-registered and innovation-driven techbio company, has partnered with the research group led by Professor David E. Olson at the University of California, Davis to characterize the in vivo effects of several of their novel psychoplastogens.

Fobi Announces Launch of New Access & Healthcare Solutions with Draganfly and Empower Clinics on March 1st with Joint Webinar

Joint solutions leverage the new PassPro Wallet pass platform to deliver more interoperable and automated access and healthcare solutions

Using Smart Sensors and Cloud-based Analytics, Canary’s 20-minute Handheld COVID-19 Saliva-based Molecular Test with PCR Quality Results Achieves CE Mark

• Rapid molecular PCR-like accurate saliva-based test delivers 95% sensitivity and 98% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants • Designed for point-of-care (POC) diagnosis, ease of use, rapid and cost-effective mass-screening • A mobile-enabled, multiplex platform and connected solution enables efficient real-time reporting of results, track & trace, and surveillance

ProMIS Neurosciences to Participate in H.C. Wainwright BioConnect 2022 Virtual Conference

[PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Mass. — January 6, 2022 — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today its participation in the H.C. Wainwright BioConnect 2022 Virtual Conference being held January 10–13, 2022.

Study shows, inhaling active form of hydrogen “suisonia” effective for Post COVID-19 syndrome

[PRESSWIRE] Japan – 21 October, 2021 — Post COVID-19 syndrome, a developing world-wide problem may be alleviated by Japan originated medical device “suisonia”.

European Campaign gives Kidneys a stage! ERA-EDTA launches the European Kidney Health Awareness Days

[PRESSWIRE] Parma, Italy – 05 May, 2021 — One in ten adults in Europe suffer from reduced kidney function and yet many will be unaware of this. What is fatal is that the loss of kidney function cannot be reversed. It is therefore essential that the general public are made aware of the importance of the kidneys and how to protect them.

CEBINA reports potency of azelastine against emerging dominant variants of SARS-CoV-2 in laboratory testing

[PRESSWIRE] Austria – 04 May, 2021 — CEBINA GmbH, an Austrian biotech company, today announces that azelastine, previously identified as a potential anti-COVID-19 drug, is equally potent against newly emerging dominant variants of SARS-CoV-2 compared to the original virus. Azelastine is available as an anti-allergy nasal spray and is currently being tested in a Phase 2 efficacy trial for the treatment of early-stage COVID-19 disease.

Eurocities calls for a minute of silence

[PRESSWIRE] Brussels – 22.03.21 — One year after the start of the corona pandemic, the city network Eurocities invites everyone to a European minute of silence. The joint commemoration takes place next Wednesday, 24 March, at 12:00 noon CET.

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

[PRESSWIRE] Vienna, Austria – 17 February, 2021 — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts around the world are focusing on identifying new anti-COVID therapeutics that includes re-evaluation of existing product portfolios with a view to re-purpose drugs that have antiviral properties.

myTamarin Launches Corporate Childcare Product Amidst The Pandemic Rollercoaster for Working Parents

[PRESSWIRE] London, UK – 12 February, 2021 — When flexible work means working parents are losing out, progressive employers are listening: it’s time to let parents choose how they would like to be supported. myTamarin.com, the leading nanny agency in London is teaming up with corporates to help them attract and retain diverse talent.

Necenti Labs pioneers COVID test that can let employers get staff back to work

[PRESSWIRE] Madrid, Spain – 25 January, 2021 — An innovative new technology from Necenti Labs offers 96% accuracy for COVID-19 detection before infection with deep data to give companies and individuals the power of knowledge to battle lockdown.

73 Nations Participate in Third COVID-19 Online Prayer Event Hosted by Shincheonji Church of Jesus

[PRESSWIRE] UK – 18.11.20 — Hundreds of religious leaders from around the world gather to pray for the end of COVID-19 ahead of a group plasma donation by 4,000 Shincheonji members…

Digiteccs unveils Digital Nation Model (D-NA) to combat security, privacy and sovereignty challenges linked to data

New policy framework for digital governance calls for fundamental re-set of data regulation across telecoms and technology industries.

Active Air Cleaning Technology from Airionex verified to destroy coronavirus in the air within a few minutes

[PRESSWIRE] CA, US – 18 September, 2020 — Airionex announced today the results of new independent testing. Varionix® active bipolar ionization air cleaning technology from Airionex has been verified to be effective for disinfecting coronavirus from the air. The virus was completely eliminated within minutes.

Nuevo manual para los ministros de finanzas: el potencial económico de las políticas de agua, saneamiento e higiene en tiempos de la COVID-19

[PRESSWIRE] London, UK – 03 September, 2020 — La alianza mundial Saneamiento y Agua para Todos (SWA) ha publicado hoy un manual innovador que recopila las mejores prácticas y orientaciones sobre el uso de la financiación pública y la recaudación de nuevos fondos para el agua, el saneamiento y la higiene. Esta información demuestra que el agua, el saneamiento y la higiene pueden desempeñar un papel central en la tarea de apoyar a los ministros responsables de las finanzas, y a los gobiernos en general, para que respondan a los apremiantes desafíos mundiales a los que nos enfrentamos, como la COVID-19, el cambio climático y las desigualdades.